This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Ngai Hang Victor Chong: Innovator in Pharmaceutical Composition
Introduction
Ngai Hang Victor Chong is a notable inventor based in Heidesheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patent.
Latest Patents
Victor Chong holds a patent for a pharmaceutical composition and dosage form comprising (E)-4-(2-(aminomethyl)-3-fluoroallyloxy)-N-tert-butylbenzamide. This invention relates to pharmaceutical compositions that utilize this compound as an active pharmaceutical ingredient. The patent emphasizes the preparation, therapeutic uses, and dosage forms of this composition, particularly focusing on its hydrochloride salt.
Career Highlights
Victor Chong is associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work at this organization has allowed him to contribute to advancements in drug development and therapeutic treatments.
Collaborations
He has collaborated with notable coworkers, including Kenji Egusa and Takuma Katayama, enhancing the innovative efforts within his team.
Conclusion
Ngai Hang Victor Chong's contributions to pharmaceutical innovations exemplify the impact of dedicated inventors in the healthcare industry. His work continues to influence therapeutic practices and drug formulations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile